Infection

Papers
(The H4-Index of Infection is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review224
A case of occupational transmission of mpox111
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study108
A severe case of Israeli spotted fever with pleural effusion in Italy106
Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency105
Coronavirus disease 2019 associated pulmonary mucormycosis94
50 Years of INFECTION: happy birthday INFECTION!88
Validation of the CHANCE score in adults and children with a suspected central nervous system infection81
Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–201772
SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)58
Infective endocarditis: statistical methods and analytical concerns54
Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 202153
A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 202253
Pharyngeal gonococcal infection and the sensitivity of oral gargle samples in comparison to self-collected throat swabs for the detection of N. gonorrhoeae in persons in Tyrol, Austria49
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry49
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests48
Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis46
Comparison of a novel antigen detection test with reverse transcription polymerase chain reaction assay for laboratory diagnosis of SARS-CoV-2 infection44
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects43
Strongyloidiasis in the COVID era: a warning for an implementation of the screening protocol41
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?41
Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center39
No link between the prevalence of hepatitis E virus infection and the diagnosis of schizophrenia38
An invasive infection caused by the thermophilic mold Talaromyces thermophilus37
Characteristics of viral pneumonia in the COVID-19 era: an update36
No evidence of an association of multiple sclerosis (MS) with Borna disease virus 1 (BoDV-1) infections in patients within an endemic region: a retrospective pilot study36
Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers35
Atypical monkeypox presentation in a previously vaccinated MSM HIV-positive adult33
Pityriasis lichenoides et varioliformis acuta associated with Epstein-Barr virus infection32
Clinical and microbiological characteristics of polymicrobial bacteremia: a retrospective, multicenter study32
A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings31
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis31
0.090126037597656